NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Novelwise Pharmaceutical Corporation
Novelwise Pharmaceutical Corporation
Bristol-Myers Squibb
Eli Lilly and Company
Eli Lilly and Company
GT Medical Technologies, Inc.
Actuate Therapeutics Inc.
Pfizer
EpicentRx, Inc.
Gradalis, Inc.
AbbVie
Merck Sharp & Dohme LLC
Celldex Therapeutics
Hoffmann-La Roche
Sanofi
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH
Abbott